Subgen AI

0.07 SEK

+2.95%

Less than 1K followers

SUBGEN

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Subgen AI

202020212022202320242025
Revenue13.31.70.1204.4
growth-%-87.1 %-94.7 %
EBITDA-10.3-76.4-86.3-56.2-46.9-38.6
EBIT-10.3-80.2-86.3-56.2-46.9-69.2
Profit before taxes-10.3-92.7-85.5-61.2-51.5-90.0
Net income-10.3-92.3-84.0-59.7-50.0-88.9
EPS-74.39-663.83-569.87-313.96-160.94-0.08
Dividend0.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

202020212022202320242025
EBITDA-%-575.1 %-5,044.4 %-62,400.0 %-18.9 %
EBIT-%-603.5 %-5,044.4 %-62,400.0 %-33.8 %
ROE-22.1 %-24.9 %-26.4 %4,117.2 %129.3 %-21.2 %
ROI-19.9 %-22.8 %-24.4 %-112.4 %-153.2 %-14.4 %